v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Jan. 30, 2026
Jan. 31, 2025
Feb. 02, 2024
Cash flows from operating activities:      
Net earnings $ 6,654 $ 6,957 $ 7,726
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 2,194 1,972 1,923
Noncash lease expense 572 520 499
Deferred income taxes 256 9 6
Asset impairment and loss on property - net 53 5 83
Gain on sale of business 0 (177) (79)
Share-based payment expense 247 221 210
Changes in operating assets and liabilities:      
Merchandise inventory – net 703 (514) 1,637
Other operating assets (243) 93 182
Accounts payable 73 633 (1,820)
Other operating liabilities (645) (94) (2,227)
Net cash provided by operating activities 9,864 9,625 8,140
Cash flows from investing activities:      
Purchases of investments (1,693) (1,286) (1,785)
Proceeds from sale/maturity of investments 1,658 1,204 1,722
Capital expenditures (2,213) (1,927) (1,964)
Proceeds from sale of property and other long-term assets 82 105 53
Acquisition of businesses - net (10,088) 0 0
Proceeds from sale of business 0 177 100
Other – net (10) (11) (27)
Net cash used in investing activities (12,264) (1,738) (1,901)
Cash flows from financing activities:      
Net change in commercial paper 0 0 (499)
Net proceeds from issuance of debt 6,974 0 2,983
Repayment of debt (2,587) (545) (601)
Proceeds from issuance of common stock under share-based payment plans 149 159 141
Cash dividend payments (2,636) (2,566) (2,531)
Repurchases of common stock (211) (4,053) (6,138)
Other – net (68) (42) (21)
Net cash provided by/(used in) financing activities 1,621 (7,047) (6,666)
Net (decrease)/increase in cash and cash equivalents (779) 840 (427)
Cash and cash equivalents, beginning of year 1,761 921 1,348
Cash and cash equivalents, end of year $ 982 $ 1,761 $ 921